Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials-Reference-Cited by-同舟云学术

Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials

Published:2022-01 Issue:1 Volume:8 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Ezzati Ali¹^ORCID,Davatzikos Christos²,Wolk David A.³⁴,Hall Charles B.⁵,Habeck Christian⁶,Lipton Richard B.¹⁵

Affiliation:

1. Department of Neurology Albert Einstein College of Medicine and Montefiore Medical Center Bronx New York USA

2. Center for Biomedical Image Computing and Analytics University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Neurology University of Pennsylvania Philadelphia Pennsylvania USA

4. Penn Memory Center Perelman Center for Advanced Medicine University of Pennsylvania Philadelphia Pennsylvania USA

5. Department of Department of Epidemiology and Population Health Albert Einstein College of Medicine Bronx New York USA

6. Department of Neurology Cognitive Neuroscience Division Columbia University New York New York USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

Reference46 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献